Optic nerve glioma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Optic nerve glioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Optic nerve glioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Optic nerve glioma surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Optic nerve glioma surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Optic nerve glioma surgery
CDC on Optic nerve glioma surgery
Optic nerve glioma surgery in the news
Blogs on Optic nerve glioma surgery
Directions to Hospitals Treating Optic nerve glioma
Risk calculators and risk factors for Optic nerve glioma surgery

Overview

Surgery is not the first-line treatment option for patients with optic nerve glioma. Surgical excision is usually reserved for patients with either progressive proptosis, blindness, exophytic chiasm tumor causing mass effect, hydrocephalus, or with increased intracranial pressure.

Surgery

• Usually surgery is not preferred for this type of tumor, but it can sometimes improve vision and/or relieve symptoms.
• If the glioma causes an increase in intracranial pressure, excision may be required.
• Surgery is not recommended among patients with residual vision.
• Surgical treatment for optic pathway gliomas usually involves either excision or biopsy of the tumor.
• Surgery is the first choice when single nerve involvement is causing either progressive disfiguring proptosis, blindness, or an exophytic chiasm tumor is causing mass effect or hydrocephalus.
• Diffuse infiltration of the chiasm is a contraindication to surgery.
• Due to damage the risk of visual loss as well as damage to surrounding neurologic structures, surgical intervention for gliomas involving the optic chiasm is considered only for obtaining a biopsy specimen of the chiasm in certain cases or for relieving hydrocephalus.
• NF-1 patients have increased risk of local recurrence after surgery than non-NF patients and tend to have less localized disease.